CCND1 and gallbladder cancer: The same outcomes were reported in a study by Bi et al., where combination therapy with Cis and Met gave rise to a G0/G1 phase cell cycle arrest in gallbladder cancer cells by upregulation of P21, P27 and downregulation of CyclinD1.